SPONSOR
Universitaire Ziekenhuizen KU Leuven
Total Trials
4
Recruiting
4
Phases
Phase 3, Phase 4
Conditions studied: Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor ReceptorCastration-resistant Prostate CancerOligoprogressiveMeningiomaPituitary DiseasePituitary AdenomaCraniopharyngiomaEndoscopic Pituitary SurgeryOlfactory DysfunctionNeutropenia, Febrile
Universitaire Ziekenhuizen KU Leuven is a clinical research sponsor with 4 registered studies on ClinicalTrials.gov, of which 4 are actively recruiting participants. Research covers conditions including Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor, Castration-resistant Prostate Cancer, Oligoprogressive, Meningioma.
The trial portfolio spans Phase 3, Phase 4 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Universitaire Ziekenhuizen KU Leuven
How many clinical trials has Universitaire Ziekenhuizen KU Leuven sponsored?
ClinicalMetric currently tracks 4 clinical trials sponsored by Universitaire Ziekenhuizen KU Leuven, of which 4 are actively recruiting participants. These trials cover conditions including Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor, Castration-resistant Prostate Cancer, Oligoprogressive. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Universitaire Ziekenhuizen KU Leuven research focus on?
Universitaire Ziekenhuizen KU Leuven clinical trials span Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor, Castration-resistant Prostate Cancer, Oligoprogressive, Meningioma, Pituitary Disease, and additional conditions. The research pipeline includes Phase 3, Phase 4 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Universitaire Ziekenhuizen KU Leuven clinical trial?
To participate in a Universitaire Ziekenhuizen KU Leuven trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Universitaire Ziekenhuizen KU Leuven trials with current recruitment status updated daily.
Clinical Trials by Universitaire Ziekenhuizen KU Leuven
NCT04216121
Recruiting
LAT for Oligoprogressive NSCLC Treated With First-line OSImertinib
Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor
NCT06585007 Phase 3
Recruiting
Metastasis-directed Therapy in Oligoprogressive Castration-refractory Prostate Cancer
Castration-resistant Prostate Cancer
NCT06874426
Recruiting
The Impact of Endoscopic Endonasal Skull Base Surgery on Olfaction
Meningioma
NCT05926063 Phase 4
Recruiting
Stopping Antibiotics After 3 Days for the Treatment of High-risk FEbrile Neutropenia
Neutropenia, Febrile
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology